My expertise is in the area of biological systems involved in the co-occurrence of psychiatric conditions and substance use. I have lead several grants and published numerous studies on the etiological and treatment processes involved in this overlap from developmental, genetic, and pharmacological perspectives. I am a licensed clinical psychologist and am highly experienced in the assessment and treatment of psychiatric and substance use disorders, including roles on randomized clinical trials. Most recently, I have focused on studies that combine laboratory and observational approaches to examine the effects of cannabinoids on psychological, cognitive, and other outcomes relevant to public health.
